|Nombre||Título||Pagar||Ejecutado||Año de nacimiento|
|Mr. Irwin David Simon||Pres, CEO & Chairman||5.2M||N/D||1958|
|Mr. Carl A. Merton||CFO & Principal Accounting Officer||642.35k||588.13k||1970|
|Mr. James R. Meiers||Pres of Canada||596.99k||N/D||1958|
|Ms. Denise Menikheim Faltischek||Head of International & Chief Strategy Officer||446.5k||N/D||1973|
|Mr. Lloyd Brathwaite||Chief Information Officer||N/D||N/D||N/D|
|Mr. John B. Sadler||VP of Investor Relations||N/D||N/D||N/D|
|Ms. Dara Redler||Interim Chief Legal Officer & Corp. Sec.||N/D||N/D||N/D|
|Mr. Bernard Yeung||Sr. VP of Sales & Marketing||N/D||N/D||N/D|
|Ms. Rita Seguin||Chief HR Officer||N/D||N/D||N/D|
|Mr. Victor Neufeld||Special Advisor||N/D||N/D||1954|
Tilray Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company offers cannabis-lifestyle and consumer packaged goods; and hemp-based foods and alcoholic beverages. It offers medical cannabis in extracts and dried flower forms; and cannabis extracts, including purified oil drops and capsules. The company supplies cannabis extract products to patients, physicians, pharmacies, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company was formerly known as Aphria Inc. and changed its name to Tilray, Inc. Tilray Inc. is based in Leamington, Canada.
La calificación ISS Governance QuickScore de Tilray, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.